FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/JNJ
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Johnson & Johnson (JNJ) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Johnson & Johnson (JNJ) trades at $273.20, down 0.73% today, with strong technical momentum showing bullish moving averages and key support at $266. The company demonstrates robust fundamentals with Q3 2026 EPS beating expectations at $2.59 versus $2.52 forecast, maintaining consistent earnings outperformance. Revenue growth trends upward from $94.2B in 2025 to projected $99.3B in 2026, supported by innovative medicine segment strength and new drug launches.
JNJ presents a favorable investment case with analyst consensus price target of $285.31 (4.4% upside) and 52.5% buy ratings. Key opportunities include dividend reliability and pipeline innovations like Icotyde psoriasis drug with $4.5B peak sales potential. Risks include patent expirations, rising debt-to-asset ratio (24.06% in 2025), and competitive pressures in pharmaceutical markets. The stock remains well-positioned for long-term growth despite near-term valuation concerns.
Read full analysis

Key Stats

  • Market Cap
    $657.68B
  • Volume
    8,968,187
  • Sector
    Health
  • 52W High
    $278.43
  • 52W Low
    $186.00
  • Typical Hold Time
    130 Days
  • Enterprise Value
    $685.10B
  • Div Yield
    1.96%
  • Trading Activity
    -
$271.54
52W Low: $186
05 Nov 2025
52W High: $278.43
03 Sep 2026

Track Johnson & Johnson (JNJ) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Johnson & Johnson has traded between a low of $186 and a high of $278.43, highlighting its annual price range. Buy and sell Johnson & Johnson shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Most Recent News

Content is generated by Aura AI

Survey finds US consumers use AI agents but distrust them with financial info, blaming companies for fraud.

A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudu...

Market News
1 hour ago
Seon
Neutral
Survey finds US consumers use AI agents but distrust them with financial info, blaming companies for fraud.

Radiopharm Theranostics advances multiple cancer drug trials, prepares Phase 3 study for brain metastases imaging.

Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...

Market News
1 hour ago
Na
Bullish
news icon
Radiopharm Theranostics advances multiple cancer drug trials, prepares Phase 3 study for brain metastases imaging.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
2 hours ago
Na
Neutral
Alvotech to present at four major investor conferences in November across Europe.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $657.68B
  • Volume
    8,968,187
  • Sector
    Health
  • 52W High
    $278.43
  • 52W Low
    $186.00
  • Typical Hold Time
    130 Days
  • Enterprise Value
    $685.10B
  • Div Yield
    1.96%
  • Trading Activity
    -
$271.54
52W Low: $186
05 Nov 2025
52W High: $278.43
03 Sep 2026

Track Johnson & Johnson (JNJ) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Johnson & Johnson has traded between a low of $186 and a high of $278.43, highlighting its annual price range. Buy and sell Johnson & Johnson shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!